Full Text:   <36>

CLC number: 

On-line Access: 2024-05-16

Received: 2023-11-14

Revision Accepted: 2024-04-22

Crosschecked: 0000-00-00

Cited: 0

Clicked: 63

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 1998 Vol.-1 No.-1 P.

http://doi.org/10.1631/jzus.B2300825


Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia


Author(s):  Yabin CHEN, Hao LI, Peihao WEN, Jiakai ZHANG, Zhihui WANG, Shengli CAO, Wenzhi GUO

Affiliation(s):  Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China; more

Corresponding email(s):   fccguowz@zzu.edu.cn

Key Words:  Liver transplantation, Epithelial sodium channel, Sodium/calcium exchanger, Hypernatremia


Yabin CHEN, Hao LI, Peihao WEN, Jiakai ZHANG, Zhihui WANG, Shengli CAO, Wenzhi GUO. Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia[J]. Journal of Zhejiang University Science B, 1998, -1(-1): .

@article{title="Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia",
author="Yabin CHEN, Hao LI, Peihao WEN, Jiakai ZHANG, Zhihui WANG, Shengli CAO, Wenzhi GUO",
journal="Journal of Zhejiang University Science B",
volume="-1",
number="-1",
pages="",
year="1998",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2300825"
}

%0 Journal Article
%T Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia
%A Yabin CHEN
%A Hao LI
%A Peihao WEN
%A Jiakai ZHANG
%A Zhihui WANG
%A Shengli CAO
%A Wenzhi GUO
%J Journal of Zhejiang University SCIENCE B
%V -1
%N -1
%P
%@ 1673-1581
%D 1998
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2300825

TY - JOUR
T1 - Pharmacological inhibition of ENaC or NCX can attenuate hepatic ischemia-reperfusion injury exacerbated by hypernatremia
A1 - Yabin CHEN
A1 - Hao LI
A1 - Peihao WEN
A1 - Jiakai ZHANG
A1 - Zhihui WANG
A1 - Shengli CAO
A1 - Wenzhi GUO
J0 - Journal of Zhejiang University Science B
VL - -1
IS - -1
SP -
EP -
%@ 1673-1581
Y1 - 1998
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2300825


Abstract: 
Donors with serum sodium concentration >155 mmol/L are extended criteria donors for liver transplantation (LT). Elevated serum sodium of donors leads to an increased incidence of hepatic dysfunction in the early postoperative period of LT; the exact mechanism has not been reported. We constructed a Lewis rat model of 70% hepatic ischemia-reperfusion (I/R) with hypernatremia and a BRL-3A cell model of hypoxia-reoxygenation (H/R) with high sodium concentration (HS) culture medium precondition. To determine the degree of injury, biochemical analysis, histological analysis, and oxidative stress and apoptosis detection were performed. We applied specific inhibitors of the epithelial sodium channel (ENaC) and Na+/Ca2+ exchanger (NCX) in vivo and in vitro to verify their role in injury. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) levels and the area of hepatic necrosis were significantly elevated in the HS + I/R group. Increased reactive oxygen species (ROS) production, MPO-positive cells, and aggravated cellular apoptosis were seen in the HS + I/R group. The HS + H/R group of BRL-3A cells showed significantly increased cellular apoptosis and ROS production compared to the H/R group. The application of Amiloride (Amil), a specific inhibitor of ENaC, reduced ischemia-reperfusion injury (IRI) aggravated by HS both in vivo and in vitro, evidenced by decreased serum transaminases, inflammatory cytokines, apoptosis, and oxidative stress. SN-6, a specific inhibitor of NCX, had a similar effect. In summary, hypernatremia aggravates hepatic ischemia-reperfusion injury (IRI), which can be attenuated by pharmacological inhibition of ENaC or NCX.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE